Haemonetics Corp (HAE)

$51.26 -0.09 (-0.18%)
Market Cap 2.47B
Revenue (ttm) 1.36B
Net Income (ttm) 167.68M
EPS (ttm) N/A
PE Ratio 11.04
Forward PE 10.70
Profit Margin 12.32%
Debt to Equity Ratio 1.04
Volume 364,000
Avg Vol 935,674
Day's Range N/A - N/A
Shares Out 48.18M
Stochastic %K 77%
Beta 0.37
Analysts Strong Sell
Price Target $78.00

Company Profile

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLy...

Industry: Medical Devices
Sector: Healthcare
Phone: 781 848 7100
Address:
125 Summer Street, Boston, United States
JarvisFlow
JarvisFlow Oct. 21 at 4:12 PM
Barrington Research updates rating for Haemonetics ( $HAE ) to Outperform, target set at 86.
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Oct. 20 at 8:11 PM
$HAE
0 · Reply
Cutlass
Cutlass Oct. 8 at 7:42 PM
$HAE Creeping up the past 2 weeks 🪄
0 · Reply
JarvisFlow
JarvisFlow Oct. 7 at 5:06 PM
Citigroup has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Buy with a target price of 78 → 64.
0 · Reply
Cutlass
Cutlass Oct. 3 at 4:14 PM
$HAE 👀
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 3:42 PM
$HAE $60
0 · Reply
JBr0
JBr0 Sep. 26 at 2:21 PM
$HAE Okay, I'm out. I don't like how this trades. Long term, I think folks are golden. However, the low volume, 111 percent "tute" ownership is killing me short term. I'm looking for quick trades right now....and yes I'm being very impatient....lol. Made a profit tho so that's a plus, but was hoping for more of a quick and significant pop. GL Bulls
1 · Reply
Cutlass
Cutlass Sep. 26 at 1:13 PM
$HAE Bought 48 -
0 · Reply
JBr0
JBr0 Sep. 25 at 8:01 PM
$HAE bought...
0 · Reply
johnmilnes
johnmilnes Sep. 25 at 7:46 PM
$HAE Gap fill from 2022
0 · Reply
Latest News on HAE
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

Oct 9, 2025, 4:05 PM EDT - 16 days ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

I'm Recommending Haemonetics Again, But With Caveats (Ratings Upgrade)

Aug 11, 2025, 12:44 PM EDT - 2 months ago

I'm Recommending Haemonetics Again, But With Caveats (Ratings Upgrade)

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

Aug 9, 2025, 10:53 PM EDT - 2 months ago

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Aug 8, 2025, 9:14 AM EDT - 2 months ago

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

Aug 7, 2025, 6:00 AM EDT - 2 months ago

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Jul 9, 2025, 4:05 PM EDT - 3 months ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 6:00 AM EDT - 5 months ago

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

May 10, 2025, 1:05 PM EDT - 6 months ago

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

May 8, 2025, 6:00 AM EDT - 6 months ago

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

Mar 31, 2025, 4:00 PM EDT - 7 months ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

Haemonetics Announces Executive Leadership Updates

Mar 3, 2025, 4:10 PM EST - 8 months ago

Haemonetics Announces Executive Leadership Updates

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Feb 24, 2025, 6:00 AM EST - 8 months ago

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 12:19 PM EST - 9 months ago

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Feb 6, 2025, 6:00 AM EST - 9 months ago

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Jan 14, 2025, 6:13 AM EST - 10 months ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Jan 8, 2025, 5:03 PM EST - 10 months ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 6:00 AM EST - 10 months ago

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Dec 3, 2024, 1:16 AM EST - 11 months ago

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript

Nov 9, 2024, 1:34 AM EST - 1 year ago

Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Nov 7, 2024, 6:00 AM EST - 1 year ago

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Oct 3, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Top 3 Health Care Stocks That Are Set To Fly This Quarter

Aug 16, 2024, 7:57 AM EDT - 1 year ago

Top 3 Health Care Stocks That Are Set To Fly This Quarter

IBRX PGNY

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Aug 15, 2024, 6:30 AM EDT - 1 year ago

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics Corporation (HAE) Q1 2025 Earnings Call Transcript

Aug 8, 2024, 1:13 PM EDT - 1 year ago

Haemonetics Corporation (HAE) Q1 2025 Earnings Call Transcript

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Aug 8, 2024, 6:00 AM EDT - 1 year ago

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Jul 30, 2024, 6:00 AM EDT - 1 year ago

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Jul 8, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth

Jun 21, 2024, 3:50 PM EDT - 1 year ago

Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

Jun 18, 2024, 4:15 PM EDT - 1 year ago

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

May 23, 2024, 6:00 AM EDT - 1 year ago

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

Haemonetics Announces Proposed Convertible Senior Notes Offering

May 21, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Announces Proposed Convertible Senior Notes Offering

Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript

May 10, 2024, 12:25 AM EDT - 1 year ago

Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript

Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

May 9, 2024, 6:00 AM EDT - 1 year ago

Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Apr 10, 2024, 4:58 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge

Apr 4, 2024, 6:30 AM EDT - 1 year ago

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge

Haemonetics Corporation Completes Acquisition of Attune Medical

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Haemonetics Corporation Completes Acquisition of Attune Medical

Haemonetics Announces Definitive Agreement to Acquire Attune Medical

Mar 5, 2024, 6:00 AM EST - 1 year ago

Haemonetics Announces Definitive Agreement to Acquire Attune Medical

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

Feb 21, 2024, 5:57 PM EST - 1 year ago

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Feb 21, 2024, 5:55 PM EST - 1 year ago

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript

Feb 8, 2024, 12:24 PM EST - 1 year ago

Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript

Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Feb 8, 2024, 6:00 AM EST - 1 year ago

Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

Jan 11, 2024, 4:05 PM EST - 1 year ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

Haemonetics Corporation Completes Acquisition of OpSens Inc.

Dec 12, 2023, 6:00 AM EST - 2 years ago

Haemonetics Corporation Completes Acquisition of OpSens Inc.

Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Dec 7, 2023, 4:05 PM EST - 2 years ago

Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Haemonetics: Solid Performance Of This Blood Play

Nov 22, 2023, 6:15 AM EST - 2 years ago

Haemonetics: Solid Performance Of This Blood Play

Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript

Nov 3, 2023, 6:21 PM EDT - 2 years ago

Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript

Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Nov 2, 2023, 6:00 AM EDT - 2 years ago

Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment

Oct 13, 2023, 4:37 PM EDT - 2 years ago

Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment

Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.

Oct 10, 2023, 6:00 AM EDT - 2 years ago

Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023

Oct 5, 2023, 4:05 PM EDT - 2 years ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023

JarvisFlow
JarvisFlow Oct. 21 at 4:12 PM
Barrington Research updates rating for Haemonetics ( $HAE ) to Outperform, target set at 86.
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Oct. 20 at 8:11 PM
$HAE
0 · Reply
Cutlass
Cutlass Oct. 8 at 7:42 PM
$HAE Creeping up the past 2 weeks 🪄
0 · Reply
JarvisFlow
JarvisFlow Oct. 7 at 5:06 PM
Citigroup has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Buy with a target price of 78 → 64.
0 · Reply
Cutlass
Cutlass Oct. 3 at 4:14 PM
$HAE 👀
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 3:42 PM
$HAE $60
0 · Reply
JBr0
JBr0 Sep. 26 at 2:21 PM
$HAE Okay, I'm out. I don't like how this trades. Long term, I think folks are golden. However, the low volume, 111 percent "tute" ownership is killing me short term. I'm looking for quick trades right now....and yes I'm being very impatient....lol. Made a profit tho so that's a plus, but was hoping for more of a quick and significant pop. GL Bulls
1 · Reply
Cutlass
Cutlass Sep. 26 at 1:13 PM
$HAE Bought 48 -
0 · Reply
JBr0
JBr0 Sep. 25 at 8:01 PM
$HAE bought...
0 · Reply
johnmilnes
johnmilnes Sep. 25 at 7:46 PM
$HAE Gap fill from 2022
0 · Reply
dkkstocks
dkkstocks Sep. 25 at 7:35 PM
$HAE relentless selloff.
0 · Reply
JarvisFlow
JarvisFlow Sep. 23 at 3:10 PM
Barrington Research has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Outperform with a target price of 86.
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Sep. 19 at 3:21 PM
$HAE
0 · Reply
Cutlass
Cutlass Sep. 17 at 3:24 PM
$HAE 50.00 filled today 📋
0 · Reply
healthcareguru
healthcareguru Sep. 17 at 2:56 PM
$HAE this is completely stupid…insanely oversold, dirt cheap at 10x fwd P/E, guidance intact, massive squeeze setup for FY2Q coming up…back to $70. 👍 $IWM $IHI $XLV
0 · Reply
Lotzlizard
Lotzlizard Sep. 17 at 2:16 PM
$HAE Finally got my shares at 50.32!!! Let’s go
0 · Reply
healthcareguru
healthcareguru Sep. 15 at 2:57 PM
$HAE Stupid oversold with clear upside to FY2Q number son deck…beat/raise (or even maintain at these levels) => SQUEEZE CITY. Buyer. 👍 $IHI $XLV $IWM $XBI
0 · Reply
RedSurge
RedSurge Sep. 15 at 9:45 AM
$HAE Cost structure pressure possible; watch productivity initiatives
0 · Reply
Cutlass
Cutlass Sep. 12 at 7:09 PM
$HAE Bought 52.15 📋
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Sep. 10 at 12:59 PM
$HAE
0 · Reply
N0_Brainers
N0_Brainers Sep. 9 at 5:45 PM
$HAE buying
0 · Reply
MacroVoyager
MacroVoyager Aug. 27 at 7:05 AM
$HAE gradually climbing, but watch for sharp reversals.
0 · Reply